Preventing relapse to drug abuse is one of the struggles faced by clinicians in order to treat patients with substance use disorders (DSM-5). There is a large body of clinical evidence suggesting differential characteristics of the disorder in men and women, which is in line with preclinical findings as well. The aim of this study was to assess differences in relapse-like behavior in methamphetamine (METH) seeking after a period of forced abstinence, which simulates the real clinical situation very well. Findings from such study might add new insights in gender differences in relapse mechanisms to previous studies, which employ a classical drug or cue-induced reinstatement procedure following the extinction training. Adult male and female Sprague-Dawley rats were used in IV self-administration procedure conducted in operant boxes using nose-poke operandi (Coulborn Instruments, USA). Active nose-poke resulted in activation of the infusion pump to deliver one intravenous infusion of METH (0.08 mg/kg). After baseline drug intake was established (maintenance phase), a period of forced abstinence was initiated and rats were kept singly in their home cages for 14 days. Finally, one reinstatement session in operant boxes was conducted. Females were found to self-administer significantly lower dose of METH. The relapse rate was assessed as a number of active nose-pokes during the reinstatement session, expressed as a percentage of active nose-poking during the maintenance phase. Females displayed approximately 300% of active nose-pokes compared to 50% in males. This indicates higher vulnerability to relapse of METH seeking behavior in female rats. This effect was detected in all females, independently of current phase of their estrous cycle. Therefore, this paradigm using operant drug self-administration and reinstatement of drug-seeking after forced abstinence model can be used for preclinical screening for potential new anti-relapse medications specific for women.

Experimental and Applied Neuropsychopharmacology Group Central European Institute of Technology Masaryk University Brno Czech Republic

Experimental and Applied Neuropsychopharmacology Group Central European Institute of Technology Masaryk University Brno Czech Republic ; Department of Pharmacology Faculty of Medicine Masaryk University Brno Czech Republic

Experimental and Applied Neuropsychopharmacology Group Central European Institute of Technology Masaryk University Brno Czech Republic ; Section of Pharmacology Department of Biomedical and Biotechnological Sciences School of Medicine University of Catania Catania Italy

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrinol (2008) 29:36–47.10.1016/j.yfrne.2007.07.003 PubMed DOI PMC

Dluzen DE, Liu B. Gender differences in methamphetamine use and responses: a review. Gend Med (2008) 5:24–35.10.1016/S1550-8579(08)80005-8 PubMed DOI

Bobzean SA, Denobrega AK, Perrotti LI. Sex differences in the neurobiology of drug addiction. Exp Neurol (2014) 259:64–74.10.1016/j.expneurol.2014.01.022 PubMed DOI

Fattore L, Melis M, Fadda P, Fratta W. Sex differences in addictive disorders. Front Neuroendocrinol (2014) 35:272–84.10.1016/j.yfrne.2014.04.003 PubMed DOI

Brecht ML, O’Brien A, Von Mayrhauser C, Anglin MD. Methamphetamine use behaviors and gender differences. Addict Behav (2004) 29:89–106.10.1016/S0306-4603(03)00082-0 PubMed DOI

Munro CA, Mccaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J, et al. Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry (2006) 59:966–74.10.1016/j.biopsych.2006.01.008 PubMed DOI

Terner J, de Wit H. Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend (2006) 84:1–13.10.1016/j.drugalcdep.2005.12.007 PubMed DOI

Brecht ML, Herbeck D. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend (2014) 139:18–25.10.1016/j.drugalcdep.2014.02.702 PubMed DOI PMC

Reichel CM, Chan CH, Ghee SM, See RE. Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats. Psychopharmacology (Berl) (2012) 223:371–80.10.1007/s00213-012-2727-8 PubMed DOI PMC

Cox BM, Young AB, See RE, Reichel CM. Sex differences in methamphetamine seeking in rats: impact of oxytocin. Psychoneuroendocrinology (2013) 38:2343–53.10.1016/j.psyneuen.2013.05.005 PubMed DOI PMC

Lynch WJ, Carroll ME. Reinstatement of cocaine self-administration in rats: sex differences. Psychopharmacology (Berl) (2000) 148:196–200.10.1007/s002130050042 PubMed DOI

Lynch WJ, Taylor JR. Sex differences in the behavioral effects of 24-h/day access to cocaine under a discrete trial procedure. Neuropsychopharmacology (2004) 29:943–51.10.1038/sj.npp.1300389 PubMed DOI

Klein LC, Popke EJ, Grunberg NE. Sex differences in effects of predictable and unpredictable footshock on fentanyl self-administration in rats. Exp Clin Psychopharmacol (1997) 5:99–106.10.1037/1064-1297.5.2.99 PubMed DOI

Fuchs RA, Branham RK, See RE. Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen. J Neurosci (2006) 26:3584–8.10.1523/JNEUROSCI.5146-05.2006 PubMed DOI PMC

Reichel CM, Bevins RA. Forced abstinence model of relapse to study pharmacological treatments of substance use disorder. Curr Drug Abuse Rev (2009) 2:184–94.10.2174/1874473710902020184 PubMed DOI PMC

Yahyavi-Firouz-Abadi N, See RE. Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther (2009) 124:235–47.10.1016/j.pharmthera.2009.06.014 PubMed DOI PMC

Kucerova J, Vrskova D, Sulcova A. Impact of repeated methamphetamine pretreatment on intravenous self-administration of the drug in males and estrogenized or non- estrogenized ovariectomized female rats. Neuro Endocrinol Lett (2009) 30:663–70. PubMed

Castelli MP, Fadda P, Casu A, Spano MS, Casti A, Fratta W, et al. Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones. Curr Pharm Des (2013) 20(13):2100–13.10.2174/13816128113199990430 PubMed DOI

Feltenstein MW, Henderson AR, See RE. Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle. Psychopharmacology (Berl) (2011) 216:53–62.10.1007/s00213-011-2187-6 PubMed DOI PMC

Chen HH, Yang YK, Yeh TL, Cherng CF, Hsu HC, Hsiao SY, et al. Methamphetamine-induced conditioned place preference is facilitated by estradiol pretreatment in female mice. Chin J Physiol (2003) 46:169–74. PubMed

Carroll ME, Anker JJ. Sex differences and ovarian hormones in animal models of drug dependence. Horm Behav (2010) 58:44–56.10.1016/j.yhbeh.2009.10.001 PubMed DOI

Anker JJ, Carroll ME. Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci (2011) 8:73–96.10.1007/7854_2010_93 PubMed DOI

Quinones-Jenab V, Jenab S. Progesterone attenuates cocaine-induced responses. Horm Behav (2010) 58:22–32.10.1016/j.yhbeh.2009.10.002 PubMed DOI

Lynch WJ, Sofuoglu M. Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharmacol (2010) 18:451–61.10.1037/a0021265 PubMed DOI PMC

Schindler CW, Bross JG, Thorndike EB. Gender differences in the behavioral effects of methamphetamine. Eur J Pharmacol (2002) 442:231–5.10.1016/S0014-2999(02)01550-9 PubMed DOI

Mathews IZ, McCormick CM. Female and male rats in late adolescence differ from adults in amphetamine-induced locomotor activity, but not in conditioned place preference for amphetamine. Behav Pharmacol (2007) 18:641–50.10.1097/FBP.0b013e3282effbf5 PubMed DOI

Silverman JL, Koenig JI. Evidence for the involvement of ERbeta and RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior. Horm Behav (2007) 52:146–55.10.1016/j.yhbeh.2007.03.017 PubMed DOI PMC

Milesi-Halle A, Mcmillan DE, Laurenzana EM, Byrnes-Blake KA, Owens SM. Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats. Pharmacol Biochem Behav (2007) 86:140–9.10.1016/j.pbb.2006.12.018 PubMed DOI PMC

Milesi-Halle A, Hambuchen MD, Mcmillan DE, Michael Owens S. The pharmacokinetics of methamphetamine self-administration in male and female rats. Drug Alcohol Depend (2015) 150:164–9.10.1016/j.drugalcdep.2015.02.032 PubMed DOI PMC

Emmett-Oglesby MW, Peltier RL, Depoortere RY, Pickering CL, Hooper ML, Gong YH, et al. Tolerance to self-administration of cocaine in rats: time course and dose-response determination using a multi-dose method. Drug Alcohol Depend (1993) 32:247–56.10.1016/0376-8716(93)90089-9 PubMed DOI

Vinklerova J, Novakova J, Sulcova A. Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. J Psychopharmacol (2002) 16:139–43.10.1177/026988110201600204 PubMed DOI

Kucerova J, Pistovcakova J, Vrskova D, Dusek L, Sulcova A. The effects of methamphetamine self-administration on behavioural sensitization in the olfactory bulbectomy rat model of depression. Int J Neuropsychopharmacol (2012) 15:1503–11.10.1017/S1461145711001684 PubMed DOI

Amchova P, Kucerova J, Giugliano V, Babinska Z, Zanda MT, Scherma M, et al. Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms. Front Pharmacol (2014) 5:44.10.3389/fphar.2014.00044 PubMed DOI PMC

Kucerova J, Novakova J, Landa L, Sulcova A. Gender differences in cannabinoid and ecstasy interacting effects in mice. Homeost Health Dis (2006) 44:2.

Kucerova J, Sulcova A. Comparison of behavioural sensitization to ecstasy in mouse males and ovariectomized females with and without oestrogen substitution. Homeost Health Dis (2008) 50:2.

Robinson TE, Becker JB, Presty SK. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res (1982) 253:231–41.10.1016/0006-8993(82)90690-4 PubMed DOI

Stohr T, Schulte Wermeling D, Weiner I, Feldon J. Rat strain differences in open-field behavior and the locomotor stimulating and rewarding effects of amphetamine. Pharmacol Biochem Behav (1998) 59:813–8.10.1016/S0091-3057(97)00542-X PubMed DOI

Becker JB, Perry AN, Westenbroek C. Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol Sex Differ (2012) 3:14.10.1186/2042-6410-3-14 PubMed DOI PMC

Grilly DM, Loveland A. What is a “low dose” of d-amphetamine for inducing behavioral effects in laboratory rats? Psychopharmacology (Berl) (2001) 153:155–69.10.1007/s002130000580 PubMed DOI

Milesi-Halle A, Hendrickson HP, Laurenzana EM, Gentry WB, Owens SM. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats. Toxicol Appl Pharmacol (2005) 209:203–13.10.1016/j.taap.2005.04.007 PubMed DOI

Robinson TE. Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berl) (1984) 84:466–75.10.1007/BF00431451 PubMed DOI

van Haaren F, Meyer ME. Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol Biochem Behav (1991) 39:923–7.10.1016/0091-3057(91)90054-6 PubMed DOI

Harrod SB, Booze RM, Welch M, Browning CE, Mactutus CF. Acute and repeated intravenous cocaine-induced locomotor activity is altered as a function of sex and gonadectomy. Pharmacol Biochem Behav (2005) 82:170–81.10.1016/j.pbb.2005.08.005 PubMed DOI

Vansickel AR, Stoops WW, Rush CR. Human sex differences in d-amphetamine self-administration. Addiction (2010) 105:727–31.10.1111/j.1360-0443.2009.02858.x PubMed DOI PMC

Vansickel AR, Lile JA, Stoops WW, Rush CR. Similar discriminative-stimulus effects of D-amphetamine in women and men. Pharmacol Biochem Behav (2007) 87:289–96.10.1016/j.pbb.2007.05.003 PubMed DOI PMC

Kennedy AP, Epstein DH, Phillips KA, Preston KL. Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life. Drug Alcohol Depend (2013) 132:29–37.10.1016/j.drugalcdep.2012.12.025 PubMed DOI PMC

Roth ME, Cosgrove KP, Carroll ME. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci Biobehav Rev (2004) 28:533–46.10.1016/j.neubiorev.2004.08.001 PubMed DOI

Roth ME, Carroll ME. Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats. Psychopharmacology (2004) 172:443–9.10.1007/s00213-003-1670-0 PubMed DOI

Justice AJ, De Wit H. Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav (2000) 66:509–15.10.1016/S0091-3057(00)00218-5 PubMed DOI

Justice AJ, De Wit H. Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology (2000) 71:51–9.10.1159/000054520 PubMed DOI

Becker JB, Molenda H, Hummer DL. Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann N Y Acad Sci (2001) 937:172–87.10.1111/j.1749-6632.2001.tb03564.x PubMed DOI

White TL, Justice AJ, De Wit H. Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav (2002) 73:729–41.10.1016/S0091-3057(02)00818-3 PubMed DOI

Peck JA, Ranaldi R. Drug abstinence: exploring animal models and behavioral treatment strategies. Psychopharmacology (Berl) (2014) 231:2045–58.10.1007/s00213-014-3517-2 PubMed DOI

Perry JL, Nelson SE, Carroll ME. Impulsive choice as a predictor of acquisition of IV cocaine self- administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol (2008) 16:165–77.10.1037/1064-1297.16.2.165 PubMed DOI

Olfactory Bulbectomy Model of Depression Lowers Responding for Food in Male and Female Rats: The Modulating Role of Caloric Restriction and Response Requirement

The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology

The effect of CNQX on self-administration: present in nicotine, absent in methamphetamine model

Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia

Sex and Feeding Status Differently Affect Natural Reward Seeking Behavior in Olfactory Bulbectomized Rats

Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia